ANK was used in small pilot studies of combination regimens in advanced metastatic colorectal cancer with long-lasting tumor stabilization [63] and in HER2-negative metastatic breast cancer with a reduction in or stabilization of the tumor volume [64]. The gene discussed is ERBB2; the disease is neoplasm.